Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Superinvestors holding CDTX, Q4 2025
3 superinvestors report holding Cidara Therapeutics, Inc. on Form 13F, worth $172.4M in total. Weight is Cidara Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q3 2025.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | 1.1% | 455,978 | $100.7M | Added+9.2% |
| Soros Fund ManagementGeorge Soros | 0.8% | 275,000 | $60.7M | New |
| Duquesne Family OfficeStanley Druckenmiller | 0.3% | 49,495 | $10.9M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CDTX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2025
3 superinvestors holding at quarter end
- New
- Soros Fund Management, Duquesne Family Office
- Added
- Maverick Capital (+9.2%)
Q3 2025
1 superinvestor holding at quarter end